CD4 and systemic lupus erythematosus: NFIL3 was highly expressed in CD4+ T cells from systemic lupus erythematosus (SLE) patients compared with those from healthy controls, and NFIL3 inhibited the self-reactivity of T cells by decreasing CD40L expression (11).